Lupus arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 23, Issue 4, 2009, Pages 495-506

  Grossman, Jennifer M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

arthritis; AVN; systemic lupus erythematosus; treatment

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BELIMUMAB; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MEPACRINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PRASTERONE; PREDNISONE; RITUXIMAB; SALICYLIC ACID; TACROLIMUS;

ARTHRITIS; ARTHROPATHY; ASEPTIC MENINGITIS; AVASCULAR NECROSIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CERVICAL SPINE DISLOCATION; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DRUG INTERMITTENT THERAPY; ESCHERICHIA COLI; EYE DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; JOINT ASPIRATION; LEUKOCYTE COUNT; LIVER DISEASE; LYMPHOCYTE COUNT; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL THERAPY; PHOTOSENSITIVITY; PHYSIOTHERAPY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SACROILIITIS; SALMONELLA; SKIN MANIFESTATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; TENDINITIS; TENDON RUPTURE; TENOSYNOVITIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ALGORITHMS; ANTIMALARIALS; ARTHRITIS; EXERCISE THERAPY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEONECROSIS;

EID: 67649757144     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.04.003     Document Type: Review

References (105)

1. Fessel W.J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 134 6 (1974 Dec) 1027-1035
2. Dubois E.L., and Tuffanelli D.L. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190 (1964 Oct 12) 104-111
3. Vitali C., Bencivelli W., Isenberg D.A., et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 10 5 (1992 Sep) 527-539
4. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8 3 (1995 Sep) 137-145
5. Sestak A.L., Nath S.K., Kelly J.A., et al. Patients with familial and sporadic onset SLE have similar clinical profiles but vary profoundly by race. Lupus 17 11 (2008 Nov) 1004-1009
6. Labowitz R., and Schumacher Jr. H.R. Articular manifestations of systemic lupus erythematosus. Ann Intern Med 74 6 (1971 Jun) 911-921
7. Hoffman I.E., Peene I., Meheus L., et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis 63 9 (2004 Sep) 1155-1158
8. Lee S.S. Symptomatic unilateral sacroiliitis in systemic lupus erythematosus. Lupus 4 4 (1995 Aug) 328-329
9. Kohli M., and Bennett R.M. Sacroiliitis in systemic lupus erythematosus. J Rheumatol 21 1 (1994 Jan) 170-171
10. Vivas J., and Tiliakos N.A. Sacroiliitis in male systemic lupus erythematous. Scand J Rheumatol 14 4 (1985) 441
11. Wallace D.J. The Musculoskeletal system. Dubois lupus erythematosus (2007) 647-662
12. Klemp P., Meyers O.L., and Keyzer C. Atlanto-axial subluxation in systemic lupus erythematosus: a case report. S Afr Med J 52 8 (1977 Aug 13) 331-332
13. Isenberg D.A., Tookman A., White A.G., et al. Erosive rheumatoid arthritis co-existing with systemic lupus erythematosus. A report of a case, also showing atlanto-axial subluxation. Clin Rheumatol 1 3 (1982 Sep) 216-220
14. Babini S.M., Cocco J.A., Babini J.C., et al. Atlantoaxial subluxation in systemic lupus erythematosus: further evidence of tendinous alterations. J Rheumatol 17 2 (1990 Feb) 173-177
15. Santiago M.B., and Galvao V. Jaccoud arthropathy in systemic lupus erythematosus: analysis of clinical characteristics and review of the literature. Medicine (Baltimore) 87 1 (2008 Jan) 37-44
16. Reilly P.A., Evison G., McHugh N.J., and Maddison P.J. Arthropathy of hands and feet in systemic lupus erythematosus. J Rheumatol 17 6 (1990 Jun) 777-784
17. Esdaile J.M., Danoff D., Rosenthall L., and Gutkowski A. Deforming arthritis in systemic lupus erythematosus. Ann Rheum Dis 40 2 (1981 Apr) 124-126
18. Alarcon-Segovia D., Abud-Mendoza C., Diaz-Jouanen E., et al. Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol 15 1 (1988 Jan) 65-69
19. Mediwake R., Isenberg D.A., Schellekens G.A., and van Venrooij W.J. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 60 1 (2001 Jan) 67-68
20. van Vugt R.M., Derksen R.H., Kater L., and Bijlsma J.W. Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis 57 9 (1998 Sep) 540-544
21. Morley K.D., Leung A., and Rynes R.I. Lupus foot. Br Med J (Clin Res Ed) 284 6315 (1982 Feb 20) 557-558
22. Paredes J.G., Lazaro M.A., Citera G., et al. Jaccoud's arthropathy of the hands in overlap syndrome. Clin Rheumatol 16 1 (1997 Jan) 65-69
23. Kramer L., Ruderman J.E., Dubois E.L., and Friou G.J. Deforming, nonerosive arthritis of the hands in chronic systemic lupus erythematosus (SLE). Arthritis Rheum 13 3 (1970) 329-330
24. Russell A.S., Percy J.S., Rigal W.M., and Wilson G.L. Deforming arthropathy in systemic lupus erthematosus. Ann Rheum Dis 33 3 (1974 May) 204-209
25. Franceschini F., Cretti L., Quinzanini M., et al. Deforming arthropathy of the hands in systemic lupus erythematosus is associated with antibodies to SSA/Ro and to SSB/La. Lupus 3 5 (1994 Oct) 419-422
26. Pipili C., Sfritzeri A., and Cholongitas E. Deforming arthropathy in SLE: review in the literature apropos of one case. Rheumatol Int (2008 Dec 9)
27. Panush R.S., Edwards N.L., Longley S., and Webster E. 'Rhupus' syndrome. Arch Intern Med 148 7 (1988 Jul) 1633-1636
28. Mezcua-Guerra L.M., Springall R., Marquez-Velasco R., et al. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study. Arthritis Res Ther 8 5 (2006) R144
29. Damian-Abrego G.N., Cabiedes J., and Cabral A.R. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 17 4 (2008) 300-304
30. Chan M.T., Owen P., Dunphy J., et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 35 1 (2008 Jan) 77-83
31. Isenberg D.A., Steiner G., and Smolen J.S. Clinical utility and serological connections of anti-RA33 antibodies in systemic lupus erythematosus. J Rheumatol 21 7 (1994 Jul) 1260-1263
32. Iagnocco A., Ossandon A., Coari G., et al. Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study. Clin Exp Rheumatol 22 5 (2004 Sep) 621-624
33. Boutry N., Hachulla E., Flipo R.M., et al. MR imaging findings in hands in early rheumatoid arthritis: comparison with those in systemic lupus erythematosus and primary Sjogren syndrome. Radiology 236 2 (2005 Aug) 593-600
34. Aydin S., Atagunduz P., Filippucci E., et al. A rare case of spontaneous, bilateral Achilles tendon rupture in systemic lupus erythematosus and a review of the literature. Lupus 17 11 (2008 Nov) 1051-1052
35. Cooney Jr. L.M., Aversa J.M., and Newman J.H. Insidious bilateral infrapatellar tendon rupture in a patient with systemic lupus erythematosus. Ann Rheum Dis 39 6 (1980 Dec) 592-595
36. Furie R.A., and Chartash E.K. Tendon rupture in systemic lupus erythematosus. Semin Arthritis Rheum 18 2 (1988 Nov) 127-133
37. Muniain M., and Spilberg I. Opera-glass deformity and tendon rupture in a patient with systemic lupus erythematosus. Clin Rheumatol 4 3 (1985 Sep) 335-339
38. Pritchard C.H., and Berney S. Patellar tendon rupture in systemic lupus erythematosus. J Rheumatol 16 6 (1989 Jun) 786-788
39. Twining R.H., Marcus W.Y., and Garey J.L. Tendon rupture in systemic lupus erythematosus. JAMA 189 (1964 Aug 3) 377-378
40. Potasman I., and Bassan H.M. Multiple tendon rupture in systemic lupus erythematosus: case report and review of the literature. Ann Rheum Dis 43 2 (1984 Apr) 347-349
41. Goldenberg D.L., and Cohen A.S. Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) 57 3 (1978 May) 239-252
42. Pekin Jr. T.J., and Zvaifler N.J. Synovial fluid findings in systemic lupus erythematosus (SLE). Arthritis Rheum 13 6 (1970 Nov) 777-785
43. Leskinen R.H., Skrifvars B.V., Laasonen L.S., and Edgren K.J. Bone lesions in systemic lupus erythematosus. Radiology 153 2 (1984 Nov) 349-352
44. Weissman B.N., Rappoport A.S., Sosman J.L., and Schur P.H. Radiographic findings in the hands in patients with systemic lupus erythematosus. Radiology 126 2 (1978 Feb) 313-317
45. Wright S., Filippucci E., Grassi W., et al. Hand arthritis in systemic lupus erythematosus: an ultrasound pictorial essay. Lupus 15 8 (2006) 501-506
46. Huang J.L., Hung J.J., Wu K.C., et al. Septic arthritis in patients with systemic lupus erythematosus: salmonella and nonsalmonella infections compared. Semin Arthritis Rheum 36 1 (2006 Aug) 61-67
47. Picillo U., Italian G., Marcialis M.R., et al. Bilateral femoral osteomyelitis with knee arthritis due to Salmonella enteritidis in a patient with systemic lupus erythematosus. Clin Rheumatol 20 1 (2001) 53-56
48. Lim E., Koh W.H., Loh S.F., et al. Non-typhoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 10 2 (2001) 87-92
49. Quismorio F.P., and Dubois E.L. Septic arthritis in systemic lupus erythematosus. J Rheumatol 2 1 (1975 Mar) 73-82
50. Yun J.E., Lee S.W., Kim T.H., et al. The incidence and clinical characteristics of Mycobacterium tuberculosis infection among systemic lupus erythematosus and rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20 2 (2002 Mar) 127-132
51. Dubois E.L., and Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174 (1960 Oct 22) 966-971
52. Gladman D.D., Chaudhry-Ahluwalia V., Ibanez D., et al. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatol 28 10 (2001 Oct) 2226-2229
53. Dimant J., Ginzler E.M., Diamond H.S., et al. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol 5 2 (1978) 136-141
54. Fialho S.C., Bonfa E., Vitule L.F., et al. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus. Lupus 16 4 (2007) 239-244
55. Ibanez D., Gladman D.D., and Urowitz M.B. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. J Rheumatol 32 5 (2005 May) 824-827
56. Cozen L., and Wallace D.J. Avascular necrosis in systemic lupus erythematosus: clinical associations and a 47-year perspective. Am J Orthop 27 5 (1998 May) 352-354
57. Campos L.M., Kiss M.H., D'Amico E.A., and Silva C.A. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 12 11 (2003) 820-826
58. Mok C.C., Lau C.S., and Wong R.W. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 37 8 (1998 Aug) 895-900
59. Mok M.Y., Farewell V.T., and Isenberg D.A. Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies?. Ann Rheum Dis 59 6 (2000 Jun) 462-467
60. Rascu A., Manger K., Kraetsch H.G., et al. Osteonecrosis in systemic lupus erythematosus, steroid-induced or a lupus-dependent manifestation?. Lupus 5 4 (1996 Aug) 323-327
61. Alarcon-Segovia D., Deleze M., Oria C.V., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 68 6 (1989 Nov) 353-365
62. Tektonidou M.G., Malagari K., Vlachoyiannopoulos P.G., et al. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 48 3 (2003 Mar) 732-736
63. Assouline-Dayan Y., Chang C., Greenspan A., et al. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32 2 (2002 Oct) 94-124
64. Nagasawa K., Tada Y., Koarada S., et al. Prevention of steroid-induced osteonecrosis of femoral head in systemic lupus erythematosus by anti-coagulant. Lupus 15 6 (2006) 354-357
65. Klippel J.H., Gerber L.H., Pollak L., and Decker J.L. Avascular necrosis in systemic lupus erythematosus. Silent symmetric osteonecroses. Am J Med 67 1 (1979 Jul) 83-87
66. Mont M.A., Marulanda G.A., Jones L.C., et al. Systematic analysis of classification systems for osteonecrosis of the femoral head. J Bone Joint Surg Am 88 Suppl. 3 (2006 Nov) 16-26
67. Marker D.R., Seyler T.M., McGrath M.S., et al. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 90 Suppl. 4 (2008 Nov) 175-187
68. Petrigliano F.A., and Lieberman J.R. Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res 465 (2007 Dec) 53-62
69. Wallace D.J., Metzger A.L., and Klinenberg J.R. NSAID usage patterns by rheumatologists in the treatment of SLE. J Rheumatol 16 4 (1989 Apr) 557-560
70. Ostensen M., and Villiger P.M. Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus. Lupus 10 3 (2001) 135-139
71. Kalia S., and Dutz J.P. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 20 4 (2007 Jul) 160-174
72. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 6881 (2002 Apr 11) 603-607
73. Williams H.J., Egger M.J., Singer J.Z., et al. Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. J Rheumatol 21 8 (1994 Aug) 1457-1462
74. Meinao I.M., Sato E.I., Andrade L.E., et al. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. Lupus 5 3 (1996 Jun) 237-241
75. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. N Engl J Med 324 3 (1991 Jan 17) 150-154
76. Tsakonas E., Joseph L., Esdaile J.M., et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus 7 2 (1998) 80-85
77. Ruiz-Irastorza G., Ramos-Casals M., Brito-Zeron P., and Khamashta M.A. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2008 Dec 22)
78. Cronstein B.N. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 39 12 (1996 Dec) 1951-1960
79. Carneiro J.R., and Sato E.I. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol 26 6 (1999 Jun) 1275-1279
80. Fortin P.R., Abrahamowicz M., Ferland D., et al. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 59 12 (2008 Dec 15) 1796-1804
81. Gansauge S., Breitbart A., Rinaldi N., and Schwarz-Eywill M. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease). Ann Rheum Dis 56 6 (1997 Jun) 382-385
82. Rahman P., Humphrey-Murto S., Gladman D.D., and Urowitz M.B. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol 25 2 (1998 Feb) 243-246
83. Wilson K., and Abeles M.A. 2 year, open ended trial of methotrexate in systemic lupus erythematosus. J Rheumatol 21 9 (1994 Sep) 1674-1677
84. Tam L.S., Li E.K., Wong C.K., et al. Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus. Lupus 13 8 (2004) 601-604
85. Remer C.F., Weisman M.H., and Wallace D.J. Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study. Lupus 10 7 (2001) 480-483
86. Grootscholten C., Ligtenberg G., Hagen E.C., et al. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int 70 4 (2006 Aug) 732-742
87. Contreras G., Tozman E., Nahar N., and Metz D. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide. Lupus 14 Suppl. 1 (2005) s33-s38
88. Sztejnbok M., Stewart A., Diamond H., and Kaplan D. Azathioprine in the treatment of systemic lupus erythematosus. A controlled study. Arthritis Rheum 14 5 (1971 Sep) 639-645
89. Ginzler E., Sharon E., Diamond H., and Kaplan D. Long-term maintenance therapy with azathioprine in systemic lupus erythematosus. Arthritis Rheum 18 1 (1975 Jan) 27-34
90. Sharon E., Kaplan D., and Diamond H.S. Exacerbation of systemic lupus erythematosus after withdrawal of azathioprine therapy. N Engl J Med 288 3 (1973 Jan 18) 122-124
91. Ginzler E.M., Dooley M.A., Aranow C., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 21 (2005 Nov 24) 2219-2228
92. Ong L.M., Hooi L.S., Lim T.O., et al. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis. Nephrology (Carlton) 10 5 (2005 Oct) 504-510
93. Bijl M., Horst G., Bootsma H., et al. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk. Ann Rheum Dis 62 6 (2003 Jun) 534-539
94. Karim M.Y., Alba P., Cuadrado M.J., et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) 41 8 (2002 Aug) 876-882
95. Van Vollenhoven R.F., Engleman E.G., and McGuire J.L. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 38 12 (1995 Dec) 1826-1831
96. Petri M.A., Lahita R.G., Van Vollenhoven R.F., et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 46 7 (2002 Jul) 1820-1829
97. Petri M.A., Mease P.J., Merrill J.T., et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum 50 9 (2004 Sep) 2858-2868
98. Chang D.M., Lan J.L., Lin H.Y., and Luo S.F. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46 11 (2002 Nov) 2924-2927
99. Tokuda M., Kurata N., Mizoguchi A., et al. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 37 4 (1994 Apr) 551-558
100. Duddridge M., and Powell R.J. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis 56 11 (1997 Nov) 690-692
101. Garcia-Carrasco M., Jimenez-Hernandez M., Escarcega R.O., et al. Use of rituximab in patients with systemic lupus erythematosus: an update. Autoimmun Rev 8 4 (2009 Feb) 343-348
102. Furie R., Stohl W., Ginzler E.M., et al. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther 10 5 (2008) R109
103. Ramsey-Goldman R., Schilling E.M., Dunlop D., et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res 13 5 (2000 Oct) 262-269
104. Karlson E.W., Liang M.H., Eaton H., et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum 50 6 (2004 Jun) 1832-1841
105. Nalebuff E.A. Surgery of systemic lupus erythematosus arthritis of the hand. Hand Clin 12 3 (1996 Aug) 591-602